| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology and Toxicology, West Virginia University Health Sciences Center, Morgantown, West Virginia 26506
Permanent cell culture lines derived from human breast cancer tissue are important experimental models in the study of human breast cancer cell proliferation. In the present work, pimozide, thioridazine, W-13, and W-12 were shown to inhibit MCF-7 human breast cancer cell growth. The 50% inhibition concentration values determined in two proliferation assays, [3H]thymidine incorporation and cell number, were in close agreement for each compound tested. The order of potency for growth inhibition in the presence of 2% stripped calf serum was pimozide (K1 2 µM) > thioridazine (K1 5 µM) > W-13 (K1 15 µM) > W-12 (K1 39 µM). Similar concentrations of these compounds blocked estradiol-induced growth of MCF-7 cells, but estrogen receptor (ER) interactions do not seem to be involved. Pimozide and thioridazine had no effect on the estradiol binding properties of the MCF-7 ER, nor did pimozide interfere with the induction of progesterone receptors by estradiol. Furthermore, pimozide also inhibited incorporation of [3H]thymidine into MCF-7 cells stimulated by polypeptide hormones in serum-free medium. The K1 for pimozide in serum-free medium alone, 0.46 µM, was similar to that determined in the presence of insulin (0.42 µM), insulin-like growth factor I (0.54 µM), and epidermal growth factor (0.43 µM). The effects of pimozide on breast cancer cell growth were not limited to the MCF-7 cell line. Pimozide also blocked cell growth and [3H]thymidine incorporation into the ER-positive T47D and ZR75-1B human breast cancer cell lines and the ER-negative human breast cancer cell line, MDA-MB-231. Although numerous mechanisms of action of pimozide and thioridazine have been identified, both drugs are calmodulin antagonists at drug concentrations that inhibit breast cancer cell growth in vitro. Inhibition of MCF-7 cell growth by the selective calmodulin antagonists W-13 and W-12 is consistent with a role for calmodulin antagonism in the broad growth-inhibitory properties of pimozide. We conclude that pimozide and thioridazine may be useful in the control of estradiol- and polypeptide hormone-induced growth of ER-positive and ER-negative human breast tumors.
1 Supported by Pharmaceutical Manufacturer's Association Research Starter Awards to J. S. S. and J. F. W., The Charleston Area Medical Center Foundation, and NIH Grants 3R25CA19530, DK33631, and CA46350.
2 To whom requests for reprints should be addressed, at Department of Pharmacology & Toxicology, West Virginia University, Morgantown, WV 26506.
Received 2/23/90.
Revised 5/21/90.
This article has been cited by other articles:
![]() |
M. Tuynder, G. Fiucci, S. Prieur, A. Lespagnol, A. Geant, S. Beaucourt, D. Duflaut, S. Besse, L. Susini, J. Cavarelli, et al. Translationally controlled tumor protein is a target of tumor reversion PNAS, October 26, 2004; 101(43): 15364 - 15369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Bertolesi, C. Shi, L. Elbaum, C. Jollimore, G. Rozenberg, S. Barnes, and M. E. M. Kelly The Ca2+ Channel Antagonists Mibefradil and Pimozide Inhibit Cell Growth via Different Cytotoxic Mechanisms Mol. Pharmacol., August 1, 2002; 62(2): 210 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirooka, G. E. Bertolesi, M. E. M. Kelly, E. M. Denovan-Wright, X. Sun, J. Hamid, G. W. Zamponi, A. E. Juhasz, L. W. Haynes, and S. Barnes T-Type Calcium Channel alpha 1G and alpha 1H Subunits in Human Retinoblastoma Cells and Their Loss After Differentiation J Neurophysiol, July 1, 2002; 88(1): 196 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.A. Pantazaki and Th.S. Lialiaris A combined biochemical and cytogenetic study of thioridazine-induced damage to nucleic acids Mutagenesis, March 1, 1999; 14(2): 243 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Kirkwood, K. Homick, M. B. Dragon, and P. G. Bradford Cloning and Characterization of the Type I Inositol 1,4,5-Trisphosphate Receptor Gene Promoter. REGULATION BY 17beta -ESTRADIOL IN OSTEOBLASTS J. Biol. Chem., September 5, 1997; 272(36): 22425 - 22431. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |